TrialCNS neuroscience & therapeutics2015

Evaluating Response to High-Dose 13.3 mg/24 h Rivastigmine Patch in Patients with Severe Alzheimer's Disease.

Martin R Farlow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.